Torbafylline
Alternative Names: HWA 448; TorbaphyllineLatest Information Update: 29 Aug 1995
Price :
$50 *
At a glance
- Originator Aventis
- Developer Roche Palo Alto LLC
- Class Antibacterials; Peripheral vasodilators; Xanthines
- Mechanism of Action Phosphoric diester hydrolase inhibitors; Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Peripheral arterial occlusive disorders
Most Recent Events
- 29 Aug 1995 Discontinued-II for Peripheral arterial occlusive disorders in Germany (Unknown route)
- 29 Aug 1995 Discontinued-II for Peripheral arterial occlusive disorders in Japan (Unknown route)
- 29 Aug 1995 Discontinued-II for Peripheral arterial occlusive disorders in USA (Unknown route)